COVID caused cancer tumours to shrink in mice – new study
Few would have thought that the COVID pandemic would have a silver lining, but scientists in Chicago may just have found one.
Related Articles
Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial
Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca’s Truqap (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) demonstrated a…
Utility of p53 Immunohistochemical Staining for Risk Stratification of Mantle Cell Lymphoma
Background: Inactivating TP53 mutations in mantle cell lymphoma (MCL) are associated with poor prognosis. While next-generation sequencing (NGS) is the gold standard for assessing TP53…
Science in the Age of AI | AI for Science Forum
Eric Topol, Executive Vice President, Scripps Research, leads a conversation with:- Alison Noble, Oxford University Technikos Professor of Biomedical Enginee…
ISLB Global Survey: Oncologist Attitudes and Practices on Liquid Biopsy
About the survey This survey aims to evaluate oncologists’ attitudes, practices, and barriers to the use of liquid biopsy in clinical care. Your participation in…
Political Language in Economics
Abstract. Does academic writing in economics reflect the political orientation of economists? We use machine learning to measure partisanship in academic e
Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial
Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca’s Truqap (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) demonstrated a…
The Man Van: A pilot study of using mobile targeted case‐finding to address health inequalities in prostate cancer
Men from deprived groups are at increased risk of delayed prostate cancer diagnosis. To ease access to PSA blood testing and follow-up for ethnic minority…
As GLP-1 Use Surges, Clinicians Weigh Benefits and Risks
GLP-1 RAs to assist with weight loss have exploded in popularity. Researchers are working to identify which patients will benefit from them and their associated…
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual targeting antibody overcome antigen heterogeneity in AML
Key Points. CD70 targeted CAR-T cells secreting a CD33 T-cell engaging antibody molecule eradicate CD33 or CD70 deficient AML